- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alkem Laboratories' 51st Annual General Meeting concluded with all proposed resolutions duly approved by shareholders. Members adopted the audited financial statements for the fiscal year ending March 31, 2025, and confirmed the interim dividend while declaring the final dividend. The re-appointments of directors Mr. Mritunjay Kumar Singh and Mr. Srinivas Singh were also approved. Additionally, the appointment of Secretarial Auditors for a five-year term and the ratification of the Cost Auditor's fees for FY25 passed with significant shareholder support, reflecting strong confidence in the company's governance and operational continuity.